Why this page exists
Human oversight SOP implementation framework for healthcare provider teams under Article 14.
Timeline anchor: AI Act in force on August 1, 2024; prohibitions and literacy obligations apply on February 2, 2025; most obligations apply on August 2, 2026; additional rollout continues to August 2, 2027.
Country enforcement context
EU-wide enforcement context for Healthcare: obligations are applied consistently across member states with local supervisory execution.
Industry and risk context
Healthcare evidence baseline: Clinical and operational AI systems that influence care pathways. High-risk scenarios: clinical decision support systems, patient triage automation, care prioritization scoring. Provider risk points: incomplete technical documentation, weak clinical validation controls, insufficient post-market monitoring.
Role obligations
Provider operational duties: Maintain Annex IV technical documentation and conformity evidence Operate post-market monitoring and corrective action workflows Demonstrate quality management and robustness controls Buying committee impact typically includes Compliance, Legal, Clinical Ops, IT.
Execution plan
Human oversight SOP execution in Healthcare: override, escalation, and intervention evidence workflow mapped to Article 14 with release-safe ownership and review cadence.
Commercial fit
Commercial readiness: regulated healthcare teams need operational evidence before August 2, 2026. Annexora converts artifact requirements into delivery plans.
FAQ
Why is human oversight sop critical in healthcare?
Sector-specific operational risk makes evidence consistency and ownership visibility essential for audits.
How should deployer and provider outputs differ?
Deployers optimize operational controls; providers optimize technical documentation and lifecycle assurance.
How fast can this be implemented?
Most teams can stand up a first production-grade version in a four-week pilot with defined owners.